Pharma Market Access Insights - from Petauri Evidence
Podcast tekijän mukaan Petauri Evidence
64 Jaksot
-
Market access in the German speaking markets
Julkaistiin: 29.8.2023 -
The role of nursing in driving digital change in the NHS
Julkaistiin: 26.7.2023 -
Market access for digital therapies and digital medicines
Julkaistiin: 19.7.2023 -
A global market access journey in cannabinoid pharmaceuticals
Julkaistiin: 17.6.2023 -
Primary Care and ICBs – what is the next step in the integration journey?
Julkaistiin: 15.5.2023 -
Data-led transformation in the NHS - partnering to optimise patient care
Julkaistiin: 31.3.2023 -
Innovating for better health – research, collaboration and innovation in the NHS
Julkaistiin: 7.3.2023 -
Healthcare, economics and society – unlocking NHS collaboration
Julkaistiin: 30.1.2023 -
Specialised Commissioning in the NHS – What do you need to know now
Julkaistiin: 13.1.2023 -
Why are we waiting? - Pressures facing the NHS and how to deliver change
Julkaistiin: 29.11.2022 -
Priority setting in primary care - NHS insights
Julkaistiin: 18.10.2022 -
Integrated Care Systems go live in the NHS - reflections after 3 weeks
Julkaistiin: 9.8.2022 -
Clinical Pharmacists – exploring the scope, capabilities, and potential of this evolving NHS role
Julkaistiin: 1.8.2022 -
Transforming systems and care pathways for an integrated NHS
Julkaistiin: 21.6.2022 -
Digital value payer communication tools: How to meet the needs of your internal stakeholders and customers
Julkaistiin: 4.5.2022 -
Population to Person: How will the NHS translate population health management into impactful, person-centred service change?
Julkaistiin: 15.3.2022 -
Planning in a volatile environment: how will the NHS reconcile its competing priorities and operational planning to meet its challenges?
Julkaistiin: 11.2.2022 -
The evolving NHS: How can Pharma and Medtech support the NHS in 2022? - NHS Insights Panel Discussion
Julkaistiin: 17.1.2022 -
Optimising the NHS – How will medicines be valued in integrated systems?
Julkaistiin: 21.12.2021 -
Rare disease market access - strategic and tactical challenges facing orphan medicines entering Europe
Julkaistiin: 29.11.2021
We explore news and insights from global healthcare markets, advising how pharma and medtech need to respond and adapt their market access strategy in light of the latest insights from our experts. The podcast features insights from our associates across global healthcare, along with thought leadership from the market access and HEOR experts at Petauri Evidence.
